142 related articles for article (PubMed ID: 17764417)
1. In vitro effects of the active metabolite of leflunomide, A77 1726, on feline herpesvirus-1.
Williams CR; Sykes JE; Mehl M; MacLeod JS; Lindsay LL; Poland AM; Chen YJ; Kyles AE; Waldman WJ; Gregory CR
Am J Vet Res; 2007 Sep; 68(9):1010-5. PubMed ID: 17764417
[TBL] [Abstract][Full Text] [Related]
2. The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis.
Vrenken TE; Buist-Homan M; Kalsbeek AJ; Faber KN; Moshage H
J Hepatol; 2008 Nov; 49(5):799-809. PubMed ID: 18809221
[TBL] [Abstract][Full Text] [Related]
3. A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases.
Wang J; Sun J; Hu J; Wang C; Prinz RA; Peng D; Liu X; Xu X
FASEB J; 2020 Aug; 34(8):10132-10145. PubMed ID: 32598086
[TBL] [Abstract][Full Text] [Related]
4. Effects of sampling instrument and processing technique on DNA yield and detection rate for feline herpesvirus-1 via polymerase chain reaction assay.
Westermeyer HD; Kado-Fong H; Maggs DJ
Am J Vet Res; 2008 Jun; 69(6):811-7. PubMed ID: 18518663
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
Cao WW; Kao PN; Chao AC; Gardner P; Ng J; Morris RE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1016-30. PubMed ID: 8719445
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effects of small interfering RNAs on in vitro replication of feline herpesvirus-1.
Wilkes RP; Kania SA
Am J Vet Res; 2010 Jun; 71(6):655-63. PubMed ID: 20513181
[TBL] [Abstract][Full Text] [Related]
7. The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes.
Palmer G; Burger D; Mezin F; Magne D; Gabay C; Dayer JM; Guerne PA
Arthritis Res Ther; 2004; 6(3):R181-9. PubMed ID: 15142263
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide and malononitrilamides.
Silva Júnior HT; Morris RE
Am J Med Sci; 1997 May; 313(5):289-301. PubMed ID: 9145039
[TBL] [Abstract][Full Text] [Related]
9. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
[TBL] [Abstract][Full Text] [Related]
10. The active metabolite of leflunomide, A77 1726, attenuates inflammatory arthritis in mice with spontaneous arthritis via induction of heme oxygenase-1.
Moon SJ; Kim EK; Jhun JY; Lee HJ; Lee WS; Park SH; Cho ML; Min JK
J Transl Med; 2017 Feb; 15(1):31. PubMed ID: 28193225
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
Krisl JC; Taber DJ; Pilch N; Chavin K; Bratton C; Thomas B; McGillicuddy J; Baliga P
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1003-9. PubMed ID: 22461534
[TBL] [Abstract][Full Text] [Related]
12. Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.
Davis IC; Lazarowski ER; Chen FP; Hickman-Davis JM; Sullender WM; Matalon S
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):379-86. PubMed ID: 17541010
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide.
Mirmohammadsadegh A; Homey B; Abts HF; Köhrer K; Ruzicka T; Michel G
Biochem Pharmacol; 1998 May; 55(9):1523-9. PubMed ID: 10076546
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon-alpha on cytopathic changes and titers for feline herpesvirus-1 in primary cultures of feline corneal epithelial cells.
Sandmeyer LS; Keller CB; Bienzle D
Am J Vet Res; 2005 Feb; 66(2):210-6. PubMed ID: 15757117
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors.
Hossain MM; Margolis DM
J Acquir Immune Defic Syndr; 2001 Oct; 28(2):199-201. PubMed ID: 11588518
[No Abstract] [Full Text] [Related]
17. Effects of physiologic concentrations of l-lysine on in vitro replication of feline herpesvirus 1.
Cave NJ; Dennis K; Gopakumar G; Dunowska M
Am J Vet Res; 2014 Jun; 75(6):572-80. PubMed ID: 24866513
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells.
Bernhoff E; Tylden GD; Kjerpeseth LJ; Gutteberg TJ; Hirsch HH; Rinaldo CH
J Virol; 2010 Feb; 84(4):2150-6. PubMed ID: 19955306
[TBL] [Abstract][Full Text] [Related]
19. The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function.
Kirsch BM; Zeyda M; Stuhlmeier K; Grisar J; Smolen JS; Watschinger B; Stulnig TM; Hörl WH; Zlabinger GJ; Säemann MD
Arthritis Res Ther; 2005; 7(3):R694-703. PubMed ID: 15899055
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressants leflunomide and mycophenolic acid inhibit fibroblast IL-6 production by distinct mechanisms.
Miljkovic Dj; Samardzic T; Drakulic D; Stosic-Grujicic S; Trajkovic V
Cytokine; 2002 Aug; 19(4):181-6. PubMed ID: 12297111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]